Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Castle Biosciences, Inc. (CSTL) had Income from Continuous Operations of $-2.33M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$87.01M |
|
$-2.33M |
|
$18.32M |
|
$68.69M |
|
$90.84M |
|
$-3.83M |
|
$1.11M |
|
$-2.71M |
|
$-2.71M |
|
$-2.33M |
|
|
Income from Continuous Operations |
$-2.33M |
$-2.33M |
|
$-2.33M |
|
$-3.83M |
|
$-0.76M |
|
28.99M |
|
28.99M |
|
$-0.07 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$361.10M |
|
$97.44M |
|
$217.46M |
|
$578.56M |
|
$68.68M |
|
$9.95M |
|
$39.01M |
|
$107.68M |
|
$470.87M |
|
$371.30M |
|
$470.87M |
|
29.69M |
|
| Cash Flow Statement Financials | |
$64.35M |
|
$-60.37M |
|
$-6.96M |
|
$119.71M |
|
$116.73M |
|
$-2.98M |
|
$45.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.26 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
78.95% |
|
-4.40% |
|
-4.40% |
|
-- |
|
-3.12% |
|
-2.68% |
|
$28.37M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
1.79 |
|
2.01 |
|
44.87 |
|
-0.50% |
|
-0.63% |
|
-0.40% |
|
-0.48% |
|
$15.86 |
|
$0.98 |
|
$2.22 |
|